IMCD N.V. (0QVU.L)
| Previous close | 141.20 |
| Open | 140.85 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's range | 140.85 - 146.55 |
| 52-week range | 107.85 - 156.50 |
| Volume | |
| Avg. volume | 53,040 |
| Market cap | N/A |
| Beta (5Y monthly) | 1.05 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GlobeNewswire
Shareholders IMCD N.V. adopt all resolutions at AGM
IMCD_logo Logo IMCD ROTTERDAM, The Netherlands (14 May 2024, 17:00 hrs CEST) – IMCD N.V. ("IMCD" or "Company"), a global leading distribution partner, formulator of speciality chemicals and ingredients, announces that all resolutions proposed to the shareholders Annual General Meeting of shareholders (AGM) held today were adopted. Turn-out was high, with almost 88% of shareholder represented. The resolutions included adoption of the financial statements for the year 2023 and approval of the divi
- GlobeNewswire
IMCD reports EBITA of EUR 127 million in the first three months of 2024
IMCD_logo Logo IMCD Rotterdam, The Netherlands (26 April 2024) - IMCD N.V. (“IMCD” or “Company”), a global leading distribution partner, and formulator of speciality chemicals and ingredients, today announces its first three months 2024 results. HIGHLIGHTS Gross profit of EUR 295 million (on a constant currency basis, equal to the first three months of 2023)Operating EBITA decline of 15% to EUR 127 million (-13% on a constant currency basis)Free cash flow of EUR 106 million (first three months o
- GlobeNewswire
IMCD Spain expands its Pharmaceuticals presence with the acquisition of Cobapharma
Photo_IMCD Spain expands its Pharmaceuticals presence with the acquisition of Cobapharma Photographed from left to right:•Cristina Marti, Director API Sales and Strategy, IMCD Group•Gianluca Galimberti, General Manager, Cobapharma•Tess Hendriks, Legal Counsel M&A, IMCD Group•Fenna van Zanten, Director M&A, IMCD Group•Jose Alcover, Managing Director, IMCD Iberia & Maghreb ROTTERDAM, The Netherlands 24 April 2024 – IMCD N.V. (“IMCD” or “Company”), a leading distributor of speciality chemicals and
